These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 33298014)

  • 1. Gene expression analysis of human prostate cell lines with and without tumor metastasis suppressor CD82.
    Dodla P; Bhoopalan V; Khoo SK; Miranti C; Sridhar S
    BMC Cancer; 2020 Dec; 20(1):1211. PubMed ID: 33298014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD82/KAI1 inhibits invasion and metastasis of esophageal squamous cell carcinoma via TGF-β1.
    Zeng TD; Zheng B; Zheng W; Chen C
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5928-5937. PubMed ID: 30280774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells.
    Desai B; Rogers MJ; Chellaiah MA
    Mol Cancer; 2007 Mar; 6():18. PubMed ID: 17343740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility- and invasiveness-inhibitory activity.
    Zhou B; Liu L; Reddivari M; Zhang XA
    Cancer Res; 2004 Oct; 64(20):7455-63. PubMed ID: 15492270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KAI1/CD82, a tumor metastasis suppressor.
    Liu WM; Zhang XA
    Cancer Lett; 2006 Aug; 240(2):183-94. PubMed ID: 16260083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KAI1/CD82, Metastasis Suppressor Gene as a Therapeutic Target for Non-Small-Cell Lung Carcinoma.
    Prabhu VV; Devaraj SN
    J Environ Pathol Toxicol Oncol; 2017; 36(3):269-275. PubMed ID: 29283339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of tumor metastasis suppressor gene KAI1/CD82 in human cancer cell lines with different metastasis potential].
    Li S; Fang W; Zhong H
    Zhonghua Yi Xue Za Zhi; 1999 Sep; 79(9):708-10. PubMed ID: 11715465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of KAI1/CD82 metastasis suppressor gene is associated with loss of heterozygosity in melanoma cell lines.
    Kim YI; Shin MK; Lee JW; Chung JH; Lee MH
    Oncol Rep; 2009 Jan; 21(1):159-64. PubMed ID: 19082457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastasis suppressor KAI1/CD82 attenuates the matrix adhesion of human prostate cancer cells by suppressing fibronectin expression and β1 integrin activation.
    Lee HA; Park I; Byun HJ; Jeoung D; Kim YM; Lee H
    Cell Physiol Biochem; 2011; 27(5):575-86. PubMed ID: 21691075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metastasis suppressor CD82/KAI1 inhibits fibronectin adhesion-induced epithelial-to-mesenchymal transition in prostate cancer cells by repressing the associated integrin signaling.
    Lee J; Byun HJ; Lee MS; Jin YJ; Jeoung D; Kim YM; Lee H
    Oncotarget; 2017 Jan; 8(1):1641-1654. PubMed ID: 27926483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of telomerase, reexpression of KAI1, and abrogation of tumorigenicity by nerve growth factor in prostate cancer cell lines.
    Sigala S; Faraoni I; Botticini D; Paez-Pereda M; Missale C; Bonmassar E; Spano P
    Clin Cancer Res; 1999 May; 5(5):1211-8. PubMed ID: 10353759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetraspanin KAI1/CD82 suppresses invasion by inhibiting integrin-dependent crosstalk with c-Met receptor and Src kinases.
    Sridhar SC; Miranti CK
    Oncogene; 2006 Apr; 25(16):2367-78. PubMed ID: 16331263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling of differential expression of messenger RNA in normal, benign, and metastatic prostate cell lines.
    Chakrabarti R; Robles LD; Gibson J; Muroski M
    Cancer Genet Cytogenet; 2002 Dec; 139(2):115-25. PubMed ID: 12550771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KAI1 suppresses HIF-1α and VEGF expression by blocking CDCP1-enhanced Src activation in prostate cancer.
    Park JJ; Jin YB; Lee YJ; Lee JS; Lee YS; Ko YG; Lee M
    BMC Cancer; 2012 Mar; 12():81. PubMed ID: 22390300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic regulation of the KAI1 metastasis suppressor gene in human prostate cancer cell lines.
    Sekita N; Suzuki H; Ichikawa T; Kito H; Akakura K; Igarashi T; Nakayama T; Watanabe M; Shiraishi T; Toyota M; Yoshie O; Ito H
    Jpn J Cancer Res; 2001 Sep; 92(9):947-51. PubMed ID: 11572762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal viability of Kai1/Cd82 deficient mice.
    Risinger JI; Custer M; Feigenbaum L; Simpson RM; Hoover SB; Webster JD; Chandramouli GV; Tessarollo L; Barrett JC
    Mol Carcinog; 2014 Aug; 53(8):610-24. PubMed ID: 23401136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metastasis suppressor CD82/KAI1 represses the TGF-β
    Lee MS; Lee J; Kim YM; Lee H
    Prostate; 2019 Sep; 79(12):1400-1411. PubMed ID: 31212375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KAI-1/CD82, the molecule and clinical implication in cancer and cancer metastasis.
    Malik FA; Sanders AJ; Jiang WG
    Histol Histopathol; 2009 Apr; 24(4):519-30. PubMed ID: 19224455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetraspanin CD82 affects migration, attachment and invasion of rheumatoid arthritis synovial fibroblasts.
    Neumann E; Schwarz MC; Hasseli R; Hülser ML; Classen S; Sauerbier M; Rehart S; Mueller-Ladner U
    Ann Rheum Dis; 2018 Nov; 77(11):1619-1626. PubMed ID: 29980577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KAI1/CD82 decreases Rac1 expression and cell proliferation through PI3K/Akt/mTOR pathway in H1299 lung carcinoma cells.
    Choi UJ; Jee BK; Lim Y; Lee KH
    Cell Biochem Funct; 2009 Jan; 27(1):40-7. PubMed ID: 19107873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.